Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11,159 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Basic Science and Pathogenesis.
Jung YHH, Lee JHH Sr, Park SH. Jung YHH, et al. Among authors: park sh. Alzheimers Dement. 2024 Dec;20 Suppl 1:e092271. doi: 10.1002/alz.092271. Alzheimers Dement. 2024. PMID: 39750870
Electro-chemo-mechanics of anode-free solid-state batteries.
Sandoval SE, Haslam CG, Vishnugopi BS, Liao DW, Yoon JS, Park SH, Wang Y, Mitlin D, Hatzell KB, Siegel DJ, Mukherjee PP, Dasgupta NP, Sakamoto J, McDowell MT. Sandoval SE, et al. Among authors: park sh. Nat Mater. 2025 Jan 2. doi: 10.1038/s41563-024-02055-z. Online ahead of print. Nat Mater. 2025. PMID: 39748055 Review.
SGLT2 expression in human vasculature and heart correlates with low-grade inflammation and causes eNOS-NO/ROS imbalance.
Mroueh A, Algara-Suarez P, Fakih W, Gong DS, Matsushita K, Park SH, Amissi S, Auger C, Kauffenstein G, Meyer N, Ohlmann P, Jesel L, Pieper MP, Marchandot B, Morel O, Mazzucotelli JP, Schini-Kerth VB. Mroueh A, et al. Among authors: park sh. Cardiovasc Res. 2024 Dec 31:cvae257. doi: 10.1093/cvr/cvae257. Online ahead of print. Cardiovasc Res. 2024. PMID: 39739876
Clinical outcomes by baseline metastases in patients with renal cell carcinoma treated with lenvatinib plus pembrolizumab versus sunitinib: Post hoc analysis of the CLEAR trial.
Grünwald V, McKay RR, Buchler T, Eto M, Park SH, Takagi T, Zanetta S, Keizman D, Suárez C, Négrier S, Lee JL, Santini D, Bedke J, Staehler M, Kollmannsberger C, Choueiri TK, Motzer RJ, Burgents JE, Xie R, Okpara CE, Powles T. Grünwald V, et al. Among authors: park sh. Int J Cancer. 2024 Dec 30. doi: 10.1002/ijc.35288. Online ahead of print. Int J Cancer. 2024. PMID: 39739622
11,159 results
You have reached the last available page of results. Please see the User Guide for more information.